Bpharma SRL
The score of Bpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +85 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bpharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 05 Jul 2024
- Year ended 31 Dec 2022filed on 19 Jul 2023
- Year ended 31 Dec 2021filed on 11 Jul 2022
Bpharma's financial analysis
- Solvency43.2%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bpharma
Bpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0843.945.431
- VAT number
- BE0843945431
- Peppol
- Registered · 0208:0843945431 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Feb 2012
- Registered office
- 6280 Gerpinnes
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Bpharma (SRL) has been based in Gerpinnes since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 101,700 € and equity of 536,490 €; its revenue is not published. Its solvency stands at 43.2%, above the median of its sector (40.1%).
Companies similar to Bpharma
Companies in the same business, of comparable size and area, outside its group.
- Takeair Manufacture of basic pharmaceutical products Oudenaarde · balance sheet €1.52m
- 3GCo Activities of holding companies Wavre · balance sheet €3.66m
- Pharmacie DES Pagodes Manufacture of basic pharmaceutical products Genappe · balance sheet 383,064 €
- Antoine Pharma Retail sale of pharmaceutical products Ixelles · balance sheet €1.46m
- Pharmentum Manufacture of pharmaceutical preparations Kontich · balance sheet €1.94m
- CFG Pharma Manufacture of basic pharmaceutical products Courcelles · balance sheet 50,919 €
- S-Form Pharma Manufacture of basic pharmaceutical products Etterbeek · balance sheet 20,430 €
- Xpert Protein Manufacture of pharmaceutical preparations Ghent · balance sheet 10,960 €
Frequently asked questions about Bpharma
What is the revenue of Bpharma?
Bpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0843945431 for Bpharma, if the company is VAT-registered. Its company number (CBE) is 0843.945.431.
Where is the registered office of Bpharma?
According to the CBE register, the registered office of Bpharma is in 6280 Gerpinnes.
What is the equity of Bpharma?
At the close of the 2025 financial year, the equity of Bpharma amounts to 536,490 €, a solvency of 43.2% of total assets.
Who manages Bpharma?
The register lists 1 active mandates at Bpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →